The current valuation score of Veracyte Inc is 7.17, ranking 257 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 47.71, which is 206.47% below the recent high of 146.20 and 773.80% above the recent low of -321.44.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.